In vivo imaging of nicotinic receptor upregulation following chronic (-)-nicotine treatment in baboon using SPECT

被引:44
作者
Kassiou, M
Eberl, S
Meikle, SR
Birrell, A
Constable, C
Fulham, MJ
Wong, DF
Musachio, JL
机构
[1] Royal Prince Alfred Hosp, Dept PET & Nucl Med, Camperdown, NSW 2050, Australia
[2] Royal Prince Alfred Hosp, Dept Renal Med, Camperdown, NSW 2050, Australia
[3] Johns Hopkins Med Inst, Dept Radiol, Div Nucl Med, Baltimore, MD 21287 USA
关键词
5-[I-123]-iodo-A-85380; (-)-nicotine; nAChR upregulation; quantitative dynamic SPECT;
D O I
10.1016/S0969-8051(00)00206-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To quantify changes in neuronal nAChR binding in vivo, quantitative dynamic SPECT studies were performed with 5-[I-123]-iodo-A- 85380 in baboons pre and post chronic treatment with (-)-nicotine or saline control. Infusion of (-)-nicotine at a dose of 2.0 mg/kg/24h for 14 days resulted in plasma (-)-nicotine levels of 27.3 ng/mL. This is equivalent to that found in an average human smoker (20 cigarettes a day). In the baboon brain the regional distribution of 5-[I-123]-iodo-A-85380 was consistent with the known densities of nAChRs (thalamus > frontal cortex > cerebellum). Changes in nAChR binding were estimated from the volume of distribution (V-d) and binding potential (BP) derived from 3-compartment model fits. In the (-)-nicotine treated animal V-d was significantly increased in the thalamus (52%) and cerebellum (50%) seven days post cessation of (-)-nicotine treatment, suggesting upregulation of nAChRs. The observed 33% increase in the frontal cortex failed to reach significance. A significant increase in BP was seen in the thalamus. In the saline control animal no changes were observed in V-d or BP under any experimental conditions. In this preliminary study, we have demonstrated for the first time in vivo upregulation of neuronal nAChR binding following chronic (-)-nicotine treatment. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 47 条
[1]   Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors [J].
Abreo, MA ;
Lin, NH ;
Garvey, DS ;
Gunn, DE ;
Hettinger, AM ;
Wasicak, JT ;
Pavlik, PA ;
Martin, YC ;
DonnellyRoberts, DL ;
Anderson, DJ ;
Sullivan, JP ;
Williams, M ;
Americ, SP ;
Holladay, MW .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) :817-825
[2]   CENTRAL ACTIONS OF NICOTINE [J].
ACETO, MD ;
MARTIN, BR .
MEDICINAL RESEARCH REVIEWS, 1982, 2 (01) :43-62
[3]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[4]  
BAHT R, 1991, J NEUROCHEM, V56, P1932
[5]   EVIDENCE THAT TOBACCO SMOKING INCREASES THE DENSITY OF (-)-[H-3]NICOTINE BINDING-SITES IN HUMAN-BRAIN [J].
BENWELL, MEM ;
BALFOUR, DJK ;
ANDERSON, JM .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (04) :1243-1247
[6]  
Breese CR, 1997, J PHARMACOL EXP THER, V282, P7
[7]   Brain nicotinic receptors:: structure and regulation, role in learning and reinforcement [J].
Changeux, JP ;
Bertrand, D ;
Corringer, PJ ;
Dehaene, S ;
Edelstein, S ;
Léna, C ;
Le Novère, N ;
Marubio, L ;
Picciotto, M ;
Zoli, M .
BRAIN RESEARCH REVIEWS, 1998, 26 (2-3) :198-216
[8]   In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography [J].
Chefer, SI ;
Horti, AG ;
Lee, KS ;
Koren, AO ;
Jones, DW ;
Gorey, JG ;
Links, JM ;
Mukhin, AG ;
Weinberger, DR ;
London, ED .
LIFE SCIENCES, 1998, 63 (25) :PL355-PL360
[9]  
CLARKE PBS, 1985, J NEUROSCI, V5, P1307
[10]  
COLLINS AC, 1990, CIBA F SYMP, V152, P68